BENDAZAC SODIUM
UNII 4SW243Q44Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Bendazac Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4SW243Q44Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 23255-99-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4SW243Q44Z

CAS Registry Number

23255-99-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BENDAZAC SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C16H13N2O3.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GHFGHIKJGVMEFT-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C216505

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

23662369

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1(nc(OCC([O-])=O)c2c1cccc2)Cc3ccccc3.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bendazac Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.